Robotics company first to enter Business Weekly Awards competition
Cambridge Medical Robotics (CMR), the British company developing Versius, the next generation surgical robot, will launch its robotic system in Europe in 2018 and in international markets thereafter. The company has entered the Disruptive Technology and Life Science Innovation categories of the Awards.
Having more than doubled in size within a year, the Cambridge-based company is set to take on the large American players that are dominating the space.
CMR will help to realise the potential of minimal access surgery and aims to be one of the largest surgical robotic companies internationally in five years with a long-term ambition to have a robot in every major hospital.
Versius aims to be cost-comparable with traditional laparoscopic surgery and more affordable to hospitals and healthcare systems than existing robotic systems on the market.
In doing so, the company aims to address the six million people who undergo traditional open surgery each year, rather than having a minimal access procedure (or keyhole), which results in long stays in hospital, significantly increased chances of infection, greater pain and larger scars.
Having created a robot with a revolutionary design, the company hopes to make an impression on Business Weekly’s judging panel for the Disruptive Technology and Life Science Innovation awards.
The robot’s remarkable dexterity, flexibility and reach means that it can undertake more procedures more easily than any existing robot on the market.
This works towards the company’s mission: to make minimal access surgery available to all those who need it by breaking down the barriers that currently exist including the size, cost and complexity of current surgical robotic systems.
Designed by some of the best engineers in the world, working hand-in-hand with some of the best surgeons in the world, CMR’s robot Versius was constructed to be lightweight and easy to set up.
The arms and wristed instruments give maximum flexibility to surgeons during a procedure. Its groundbreaking design allows them to work in a way that reduces physical and mental effort for the surgeon whilst giving them the ability to undertake more procedures on patients.
The highly versatile, bio-mimicking robotic arms measure their position and force thousands of times a second to employ a technology known as ‘collaborative robotics’, making them safe to be around and easy to manoeuvre even during surgery.
Martin Frost, CEO of Cambridge Medical Robotics, said: “Robotics will help us to realise the untapped potential of minimal access surgery for surgeons and patients across the globe.
“By delivering a robotic tool that is affordable and versatile, we believe we are well positioned to realise this market’s untapped potential, and help millions of people each year get the right surgery for them.”
CMR’s team has grown at a phenomenal rate, now employing over 100 highly-skilled engineers and designers. The company has strong financial backing. In July 2016, it completed its Series A financing which raised more than $20 million and the company is expected to make a further funding announcement this month.